Amplified Sciences, Inc. logo — Lifescience In-Vitro Diagnostic Startup. Ultra-sensitive sen...

Amplified Sciences, Inc.

Lifescience In-Vitro Diagnostic Startup. Ultra-sensitive sensing tech revolutionizing #pancreaticcancer & more diseases

Founded 2016 United States West Lafayette, United States 15 employees Venture round Total: $8.66M Biotechnology, Health Care

General Information

Company Name Amplified Sciences, Inc.
Founded Year 2016
Location United States West Lafayette, United States
Founders / Decision Makers
Team member
Employees 15
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Amplified Sciences, Inc.. To contact Amplified Sciences, Inc., visit amplifiedsciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amplified Sciences, Inc. compare?

A PDF of Amplified Sciences, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amplified Sciences, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amplified Sciences, Inc.

Amplified Sciences, Inc. is a promising lifescience in-vitro diagnostic startup with the slogan "Ultra-sensitive sensing tech revolutionizing #pancreaticcancer & more diseases." Founded in 2016 in the United States, the company aims to revolutionize disease detection and preemptive healthcare. Leveraging IP licensed from Purdue University, it has developed a platform that can scale to point of care. Their flagship assay, an ultra-sensitive molecular sensing technology, is disrupting the field of #pancreaticcancer by enabling early detection and intervention. They also target other debilitating diseases in the fields of oncology and chronic kidney disease. Amplified Sciences received a significant $400.00K grant investment from the National Cancer Institute on 12 July 2023, reflecting confidence in their innovative approach to diagnostics. With its focus on biotechnology and healthcare, the company is strategically positioned to make a substantial impact on the early detection and treatment of life-threatening diseases. This startup has the potential to not only achieve commercial success but also significantly improve patient outcomes and healthcare strategies.

Business keywords: In-Vitro Diagnostics, Startup, Life Science, Ultra-Sensitive Sensing Technology, Pancreatic Cancer, Disease Detection, IP Licensing, Purdue University, Point of Care, Oncology, Chronic Kidney Disease, Liquid Biopsy, Early Detection, Molecular Sensing, Diagnostic Assays

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.58M -
24 Jul 2024
Grant $275.00K 2
Indiana Economic Development Corporation, National Science Foundation
11 Apr 2024
Grant $400.00K 1
National Cancer Institute
12 Jul 2023
Venture Round $2.58M -
08 Mar 2023
Seed Round $1.80M 10
IU Ventures, OCA Ventures +8
25 Aug 2021
Seed Round $25.00K 2
Beni VC, IU Angel Network
01 Jun 2020
Seed Round $1.00M 7
Elevate Ventures, Golden Seeds +5
24 Apr 2020

Amplified Sciences, Inc. Alternatives & Competitors

View All Alternatives
Amplified Sciences, Inc. vs

Saving lives through innovative molecular diagnostic solutions.

Post-IPO Equity
30 employees
Biotechnology, Health Care
Amplified Sciences, Inc. vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology
Amplified Sciences, Inc. vs
Predicine
Predicine United States

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees
Biotechnology, Health Care

FAQ About Amplified Sciences, Inc.

Lifescience In-Vitro Diagnostic Startup. Ultra-sensitive sensing tech revolutionizing #pancreaticcancer & more diseases
Amplified Sciences, Inc. was founded in 2016.
Amplified Sciences, Inc. is headquartered in West Lafayette, United States.
Amplified Sciences, Inc. operates in Biotechnology and Health Care. Its work centres on In-Vitro Diagnostics, Startup, Life Science and Ultra-Sensitive Sensing Technology.
Amplified Sciences, Inc. has approximately 15 employees.
Amplified Sciences, Inc. has completed 7 funding rounds, raising a total of $8.66M. The latest funding stage is Venture round.
Top alternatives and competitors to Amplified Sciences, Inc. include Mainz Biomed, Amadix, Predicine, Immunexpress Inc., PrognomiQ Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amplified Sciences, Inc. and Mainz Biomed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amplified Sciences, Inc., https://bouncewatch.com/company/amplified-sciences-inc, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes